Evidence map›Paper›PMID 35454437›Full record

ArticleMaterials (Basel, Switzerland)2022

Controlling the Size and Porosity of Sodalite Nanoparticles from Indonesian Kaolin for Pb

Maria Ulfa, Abu Masykur, Amanah Firdausa Nofitasari, Novia Amalia Sholeha, Suprapto Suprapto, Hasliza Bahruji, Didik Prasetyoko

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Maria UlfaChemistry Education Study Program, Faculty of Teacher Training and Education, Sebelas Maret University, Surakarta 57126, Indonesia.
Abu MasykurDepartment of Chemistry, Science Faculty, Sebelas Maret University, Jl Ir Sutami 36A, Surakarta 57126, Indonesia.
Amanah Firdausa NofitasariDepartment of Chemistry, Faculty of Science and Data Analytics, Institut Teknologi Sepuluh Nopember (ITS), Keputih, Sukolilo, Surabaya 60111, Indonesia.
Novia Amalia SholehaDepartment of Chemistry, Faculty of Science and Data Analytics, Institut Teknologi Sepuluh Nopember (ITS), Keputih, Sukolilo, Surabaya 60111, Indonesia.ORCID 0000-0003-2912-2338
Suprapto SupraptoDepartment of Chemistry, Faculty of Science and Data Analytics, Institut Teknologi Sepuluh Nopember (ITS), Keputih, Sukolilo, Surabaya 60111, Indonesia.ORCID 0000-0002-1490-0726
Hasliza BahrujiCentre of Advanced Material and Energy Science, University Brunei Darussalam, Bandar Seri Begawan BE 1410, Brunei.
Didik PrasetyokoDepartment of Chemistry, Faculty of Science and Data Analytics, Institut Teknologi Sepuluh Nopember (ITS), Keputih, Sukolilo, Surabaya 60111, Indonesia.ORCID 0000-0002-1065-3385
Sepuluh Nopember Institute of Technology · IDSebelas Maret University · IDUniversiti Brunei Darussalam · BN

Funding

Sebelas Maret University https://iris1103.uns.ac.id/user/insentif_jurnal.asm
6 · The paper itself

Abstract

Mesoporous sodalite nanoparticles were directly synthesized from Indonesian kaolin with the addition of CTABr as a mesopore template. The studies highlighted the importance of aging time (3-12 h) and temperature (50-80 °C) on increasing surface area and mesoporosity of sodalite. Indonesian kaolin was used without pre-treatment and transformed to sodalite following the initial molar composition of 10 Na

Indexed as

isothermkaolinkineticsPb2+ adsorptionsodalite

Identifiers

PMID35454437
PMCPMC9024775
OpenAlexW4224254567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.